Jefferson Dermatologist Quoted in Businessweek About Stem Cell Treatment for Epidermolysis Bullosa
A recent study found that the rare skin blistering disease epidermolysis bullosa may be treated by bone marrow stem cell transplant. Dr. Jouni Uitto, a dermatologist at Jefferson, told
Bloomberg Businessweek that although this type of treatment is not a cure, "lessening of the severe blistering to any degree is good news to the patients and their families."
He goes on to say that the study "raises cautious optimism that bone marrow transplantation may serve as a treatment for epidermolysis bullosa."
Read the full
"Stem Cell Treatment May Offer Hope Against Fatal Skin Disorder" article on Businessweek.com.
Publication: Bloomberg Businessweek
Published: 8/11/2010